Also known as Symbicort 160/4.5, Symbicort 80/4.5, Foradil, Oxis Turbohaler, Perforomist, Dulera 100/5, and Dulera 200/5
Formoterol (INN) or eformoterol (former BAN) is a long-acting β2-agonist used in the management of asthma and/or chronic obstructive pulmonary disease (COPD). It is marketed in four forms: a dry-powder inhaler (DPI), a metered-dose inhaler (MDI), an oral tablet, and an inhalation solution, under various trade names including Foradil/Foradile (Schering-Plough in the U.S., Novartis rest of world), Oxeze/Oxis (AstraZeneca), Atock (Astellas), Atimos (Modulite) (Chiesi), and Perforomist (Dey).Source: Wikipedia
Estimated Total Cost: $139.85 for an average of 28 days supply
Patients are most commonly prescribed formoterol to treat chronic obstructive pulmonary disease (copd), asthma, lung cancer, and apnea.